{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:23:54Z","timestamp":1793395434541,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.thromres.2023.04.016","type":"journal-article","created":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T11:17:40Z","timestamp":1682335060000},"page":"127-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Global coagulation assays in patients with chronic kidney disease and their role in predicting thrombotic risk"],"prefix":"10.1016","volume":"226","author":[{"given":"Hui Yin","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Lui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Tacey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Barit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila K.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Donnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshal","family":"Nandurkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise M.","family":"Burrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prahlad","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2023.04.016_bb0005","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2023.04.016_bb0015","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s11936-010-0075-8","article-title":"Thrombi of different pathologies: implications for diagnosis and treatment","volume":"12","author":"Santos-Gallego","year":"2010","journal-title":"Curr. Treat. Options Cardiovasc. Med."},{"key":"10.1016\/j.thromres.2023.04.016_bb0020","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.ahj.2012.09.003","article-title":"Cardiovascular risk assessment: addition of CKD and race to the Framingham equation","volume":"164","author":"Drawz","year":"2012","journal-title":"Am. Heart J."},{"key":"10.1016\/j.thromres.2023.04.016_bb0025","doi-asserted-by":"crossref","first-page":"c171","DOI":"10.1159\/000325669","article-title":"Should eGFR and albuminuria be added to the Framingham risk score? Chronic kidney disease and cardiovascular disease risk prediction","volume":"119","author":"Chang","year":"2011","journal-title":"Nephron Clin. Pract."},{"issue":"552","key":"10.1016\/j.thromres.2023.04.016_bb0030","article-title":"Kidney disease, Framingham risk scores, and cardiac and mortality outcomes","volume":"120","author":"Weiner","year":"2007","journal-title":"Am. J. Med."},{"key":"10.1016\/j.thromres.2023.04.016_bb0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/ndt\/gft209","article-title":"Hemostasis in chronic kidney disease","volume":"29","author":"Lutz","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.thromres.2023.04.016_bb0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40697-014-0021-x","article-title":"The three-year incidence of major hemorrhage among older adults initiating chronic dialysis","volume":"1","author":"Sood","year":"2014","journal-title":"Can. J. Kidney Health Dis."},{"key":"10.1016\/j.thromres.2023.04.016_bb0045","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1681\/ASN.2015050535","article-title":"The risk of major hemorrhage with CKD","volume":"27","author":"Molnar","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.thromres.2023.04.016_bb0050","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.thromres.2019.04.033","article-title":"A review of global coagulation assays \u2014 is there a role in thrombosis risk prediction?","volume":"179","author":"Lim","year":"2019","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2023.04.016_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-9560-13-1","article-title":"A general review of major global coagulation assays: thrombelastography, thrombin generation test and clot waveform analysis","volume":"13","author":"Lanc\u00e9","year":"2015","journal-title":"Thromb. J."},{"key":"10.1016\/j.thromres.2023.04.016_bb0060","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","article-title":"Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"67","author":"Levey","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.thromres.2023.04.016_bb0065","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.thromres.2017.04.009","article-title":"Significant age, race and gender differences in global coagulation assays parameters in the normal population","volume":"154","author":"Ho","year":"2017","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2023.04.016_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat. Med."},{"key":"10.1016\/j.thromres.2023.04.016_bb0075","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.04.016_bb0080","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0008-6363(02)00857-X","article-title":"Infection and inflammation and the coagulation system","volume":"60","author":"Levi","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.thromres.2023.04.016_bb0085","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00000542-199207000-00007","article-title":"The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification","volume":"77","author":"Mongan","year":"1992","journal-title":"Anesthesiology"},{"key":"10.1016\/j.thromres.2023.04.016_bb0090","first-page":"522","article-title":"Plasma D dimer: a useful marker of fibrin breakdown in renal failure","volume":"62","author":"Gordge","year":"1989","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.04.016_bb0095","first-page":"91","article-title":"Significance of urinary fibrin\/fibrinogen degradation products (FDP) D-dimer measured by a highly sensitive ELISA method with a new monoclonal antibody (DD E72) in various renal diseases","volume":"44","author":"Shibata","year":"1995","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.thromres.2023.04.016_bb0100","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.12.026","article-title":"Thrombelastography suggests hypercoagulability in patients with renal dysfunction and intracerebral hemorrhage","volume":"27","author":"Meier","year":"2018","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.thromres.2023.04.016_bb0105","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1160\/TH10-12-0785","article-title":"Haemostatic profiles assessed by thromboelastography in patients with end-stage renal disease","volume":"106","author":"Darlington","year":"2011","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.04.016_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072663","article-title":"Elevated levels of procoagulant plasma microvesicles in dialysis patients","volume":"8","author":"Burton","year":"2013","journal-title":"PloS one"},{"key":"10.1016\/j.thromres.2023.04.016_bb0115","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.thromres.2013.09.002","article-title":"Plasma haemostatic potential of haemodialysis patients assessed by thrombin generation assay: hypercoagulability in patients with vascular access thrombosis","volume":"132","author":"Jeong","year":"2013","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2023.04.016_bb0120","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/MBC.0000000000000462","article-title":"Increased fibrin formation and impaired fibrinolytic capacity in severe chronic kidney disease","volume":"27","author":"M\u00f6rtberg","year":"2016","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2023.04.016_bb0125","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1681\/ASN.2006050503","article-title":"Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action","volume":"17","author":"Eddy","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.thromres.2023.04.016_bb0130","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000175993","article-title":"Effect of single oral dose of aspirin on human platelet functions and plasma plasminogen activator inhibitor-1","volume":"83","author":"Mousa","year":"1993","journal-title":"Cardiology"},{"key":"10.1016\/j.thromres.2023.04.016_bb0135","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/ckj\/sfw080","article-title":"Cardiovascular-renal complications and the possible role of plasminogen activator inhibitor: a review","volume":"9","author":"D'Elia","year":"2016","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.thromres.2023.04.016_bb0140","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1681\/ASN.V1351279","article-title":"Determinants of modality selection among incident US dialysis patients: results from a national study","volume":"13","author":"Stack","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.thromres.2023.04.016_bb0145","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3904\/kjim.2017.141","article-title":"The pattern of choosing dialysis modality and related mortality outcomes in Korea: a national population-based study","volume":"32","author":"Kim","year":"2017","journal-title":"Korean J. Intern. Med."},{"key":"10.1016\/j.thromres.2023.04.016_bb0150","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1053\/ajkd.2002.30552","article-title":"Comorbidity and other factors associated with modality selection in incident dialysis patients: the CHOICE study. Choices for Healthy Outcomes in Caring for End-stage Renal Disease","volume":"39","author":"Miskulin","year":"2002","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.thromres.2023.04.016_bb0155","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1093\/ndt\/gfz278","article-title":"Propensity score matched mortality comparisons of peritoneal and in-centre haemodialysis: systematic review and meta-analysis","volume":"35","author":"Elsayed","year":"2020","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.thromres.2023.04.016_bb0160","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/0886022X.2019.1625788","article-title":"Comparison of peritoneal dialysis with hemodialysis on survival of diabetic patients with end-stage kidney disease: a meta-analysis of cohort studies","volume":"41","author":"Xue","year":"2019","journal-title":"Ren. Fail."},{"key":"10.1016\/j.thromres.2023.04.016_bb0165","first-page":"34","article-title":"Fibrinolysis in chronic renal failure, dialysis and renal transplantation","volume":"7","author":"Opatrn\u00fd","year":"2002","journal-title":"Ann. Transplant."},{"key":"10.1016\/j.thromres.2023.04.016_bb0170","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF02550871","article-title":"Coagulation inhibitors and fibrinolytic parameters in patients on peritoneal dialysis and haemodialysis","volume":"28","author":"Alwakeel","year":"1996","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.thromres.2023.04.016_bb0175","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0026-0495(97)90164-5","article-title":"Plasminogen activator inhibitor-1 activity in chronic renal disease and dialysis","volume":"46","author":"Irish","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.thromres.2023.04.016_bb0180","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1093\/ndt\/gft038","article-title":"Angiotensin-converting enzyme 2 activity in patients with chronic kidney disease","volume":"28","author":"Roberts","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.thromres.2023.04.016_bb0185","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D\u2019Agostino","year":"2008","journal-title":"Circulation."},{"key":"10.1016\/j.thromres.2023.04.016_bb0190","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0049-3848(11)70007-X","article-title":"Thrombin generation tests","volume":"127","author":"Castoldi","year":"2011","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2023.04.016_bb0195","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1182\/blood-2013-11-512764","article-title":"Biology of tissue factor pathway inhibitor","volume":"123","author":"Wood","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2023.04.016_bb0200","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s11239-021-02400-y","article-title":"Global coagulation assays in healthy controls: are there compensatory mechanisms within the coagulation system?","volume":"52","author":"Lim","year":"2021","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.thromres.2023.04.016_bb0205","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijcard.2014.07.026","article-title":"Inverse association of the endogenous thrombin potential (ETP) with cardiovascular death: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study","volume":"176","author":"Schneider","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.thromres.2023.04.016_bb0210","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/gerona\/glu228","article-title":"Associations between thrombin generation and the risk of cardiovascular disease patients: results from the PROSPER study","volume":"70","author":"Loeffen","year":"2015","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.thromres.2023.04.016_bb0215","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-1-4939-8597-5_12","article-title":"Badimon perfusion chamber: an ex vivo model of thrombosis","volume":"1816","author":"Zafar","year":"2018","journal-title":"Methods Mol. Biol."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823001081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823001081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:51:27Z","timestamp":1758736287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384823001081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":42,"alternative-id":["S0049384823001081"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2023.04.016","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global coagulation assays in patients with chronic kidney disease and their role in predicting thrombotic risk","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2023.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}